Bavituximab, referred to as TRWH-783, represents an unique immunotherapy approach targeting phosphatidylserine (PS). PS is typically an internal lipid present inside cell membranes; however, it's frequently exposed on https://hamzazhmu412151.blog5.net/92079737/bavituximab-a-promising-approach-to-malignant-therapy